(100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II)

Project title

超越Sorafenib---探詢肝細胞癌的新穎治療標的及生物指標-(子計畫二)肝細胞癌對Sorafenib具抗藥性的活體實驗模式:著重預測生物標記及抗藥性反轉策略之研發(II)

Internal ID

NSC101-2325-B002-040

Principal Investigator

Start Date

May 1, 2012

End Date

April 12, 2013

Partner Organizations

Project Web Site